Protagenic Therapeutics, Inc.
General ticker "PTIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.5M (TTM average)
Protagenic Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -20.8%.
Estimated limits based on current volatility of 5.9%: low 1.69$, high 1.90$
Factors to consider:
- Total employees count: 3 as of 2024
- Top business risk factors: Operating losses, Economic downturns and volatility, Regulatory and compliance, Intellectual property risks, Market acceptance and reimbursement
- Current price 66.2% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.98$, 14.58$]
- 2025-12-31 to 2026-12-31 estimated range: [3.70$, 11.33$]
Financial Metrics affecting the PTIX estimates:
- Negative: with PPE of -0.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.98 <= 0.33
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: 41.86 < Shareholder equity ratio, % of 51.80 <= 63.39
- Negative: negative Net income
Short-term PTIX quotes
Long-term PTIX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $3.56MM | $4.53MM | $5.70MM |
| Operating Income | $-3.56MM | $-4.53MM | $-5.70MM |
| Non-Operating Income | $0.00MM | $-0.47MM | $0.18MM |
| Interest Expense | $0.14MM | $0.11MM | $0.00MM |
| R&D Expense | $1.59MM | $3.32MM | $3.85MM |
| Income(Loss) | $-3.56MM | $-5.00MM | $-5.53MM |
| Profit(Loss)* | $-3.56MM | $-5.00MM | $-5.52MM |
| Stockholders Equity | $6.92MM | $3.67MM | $1.01MM |
| Assets | $8.04MM | $4.32MM | $1.96MM |
| Operating Cash Flow | $-1.99MM | $-3.70MM | $-4.22MM |
| Capital expenditure | $0.00MM | $0.15MM | $0.00MM |
| Investing Cash Flow | $1.60MM | $4.78MM | $2.80MM |
| Financing Cash Flow | $0.07MM | $0.00MM | $1.96MM |
| Earnings Per Share** | $-0.82 | $-1.15 | $-1.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.